We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

The Power of Sparse Data AI in the Pharmaceutical Industry

Article   Jun 07, 2019 | by Jukka Corander

 
The Power of Sparse Data AI in the Pharmaceutical Industry
 
 
 

RELATED ARTICLES

Nanoparticle Drug Delivery Could Offer More Effective Pain Relief Than Opioids

Article

Historically, efforts to target the substance P (SP) neurokinin 1 receptor (NK1R), for the treatment of pain have failed. These studies had one critical flaw, whilst they were targeting the right receptor, they were focusing on the wrong location.

READ MORE

Can Warehouses in the Cloud Stop Data Siloing?

Article

The value of information to many companies across the biomedical area is incalculable, but there has been a reluctance to embrace the need to properly store that data to maxmize its utility. We talked to Arawan Gajajiva, a principal solution architect at cloud data warehouse provider Matillion, to find out that can be changed.

READ MORE

Exploring the Medicinal Benefits of Cannabis Within UK Pharmaceuticals

Article

In this article, we explore how the use of cannabis within UK pharmaceuticals is expected to change, as well as the medicinal benefits offered by cannabis, and cannabinoids.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE